Revive Therapeutics Ltd C.RVV

Dr. Yo Interview positive

[1ottrunner]

I thought the interview went well and bringing Kelly along was a great idea to help describe the science behind Bucillamine.

I wasn't expecting anything ground breaking from it but was please to hear that news would drop in the next few weeks and interim analysis would complete before the new year.

Thes interim analysis often become fda approval and a very good chance of that considering the safety profile.

Some good questions posted which were not addressed, hard to do while idiots are asking when the Nasdaq uplist is going to happen.  The Nasdaq requirements are steep and right now we would need a 20 to 1 consolidation to make it 6 months on the Nas.

Hell we can't even get an OTC uplist!

[superfido10]

Revive is in a great position. The companies working on vaccines know they have to overcome and reduce considerably the numbers of serious to fatal side effects. In the past such vaccines for much less damaging viruses took years and several variations until they got it right. All RVV has to prove is that their cocktail of a safe drug, Bucillamine, is affective in reducing the inflammation in the

[CrazyProphet]

The antibody and steroid treatments are far from 100% friendly just making Revive look all the better ! Agreed was a good interview.